Pinaverium bromide: Difference between revisions

Revision as of 13:36, 29 July 2010 editPotatoBot (talk \| contribs)Bots51,239 editsm Stub sorting and placement of stub template(s)← Previous edit		Revision as of 14:00, 29 July 2010 edit undoAnypodetos (talk \| contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers39,350 editsm Not an antihypertensiveNext edit →
Line 40:		Line 40:

	{{gastrointestinal-drug-stub}}		{{gastrointestinal-drug-stub}}
	{{antihypertensive-stub}}

Revision as of 14:00, 29 July 2010

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Pinaverium bromide" – news · newspapers · books · scholar · JSTOR (February 2010) (Learn how and when to remove this message)

Pharmaceutical compound

Pinaverium bromide
Clinical data

ATC code	A03AX04 (WHO)
Identifiers
IUPAC name 4-(2-bromo-4,5-dimethoxybenzyl)-4-(2-heptan-2-yl)ethoxy]ethyl)morpholin-4-ium
CAS Number	59995-65-2
PubChem CID	40704
CompTox Dashboard (EPA)	DTXSID90860655
Chemical and physical data
Formula	C₂₆H₄₁BrNO₄
Molar mass	511.51 g/mol g·mol

Pinaverium is a drug used for functional gastrointestinal disorders. It acts as a calcium channel blocker.

Tertiary amino group	Camylofin Dicycloverine Difemerine Dihexyverine Mebeverine Oxyphencyclimine Piperidolate Rociverine Trimebutine
Quaternary ammonium compounds	Benzilone Bevonium Diphemanil Fenpiverinium Glycopyrronium Hexocyclium Isopropamide Mepenzolate Methantheline Otilonium Oxyphenonium Penthienate Pipenzolate Poldine Prifinium Propantheline Tiemonium Timepidium Tridihexethyl

Other

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.